ClinicalTrials.gg
Enrolling by invitationNCT03681977MP-PersonaUpdated Jul 12, 2024

Clinical Outcomes of MP Persona vs. Persona Knee-PS

An interventional study of Zimmer MP Persona and Zimmer Persona Knee-PS in Osteoarthritis, Knee, sponsored by Lady Davis Institute. Enrolling by invitation at 3 sites in Canada. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-12.

Sponsored by Lady Davis Institute · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
162
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Knee osteoarthritis (OA) is a highly prevalent condition that results in substantial pain and loss of function. The end stage treatment for knee OA is total knee arthroplasty (TKA), a common and safe procedure typically performed for relief of symptoms. However, an increasing number of patients are complaining about their TKA due to altered sensations between their previous joint and the implant. Although several designs have been proposed to improve these outcomes, the knee kinematics after TKA remains different from physiological kinematics. The Medial Pivot TKA design was introduced to closely mimic normal knee kinematics and create the natural feeling of the knee. This study is intended to evaluate the clinical effectiveness and ability to restore knee motion of two TKA devices: the Medial Pivot Persona TKA Zimmer design with the traditional Zimmer Persona Knee-PS. The investigator's hypothesis is that the Medial Pivot design will results in better patient outcomes and restore knee motion at natural parameters.

Read the detailed description

This is a prospective, double-blinded, randomized control study comparing the TKA Zimmer Medial Pivot Persona design to the traditional Zimmer Persona Knee-PS. Eighty patients requiring a TKA will be recruited and randomized to one of the two treatment arms following confirmation of eligibility criteria. Forty age and sex matched healthy participants with no knee OA will also be recruited to provide a comparator measure of "normal" joint motion.

Clinical follow-up visits and radiographic assessments will be performed pre- and post-operative at 6-weeks, 1-year, 2-years. Knee kinematics and self-assessment will be completed at the following intervals: pre-operative as baseline assessments for knee motion, 1-year, 2-years. Measures will include joint mechanics and neuromuscular activation during walking and stair stepping measured with motion capture and electromyography, and clinical/self assessment including pain in response to physical activity. Any other adverse events and complications (i.e, implant failure, re-operation, infection) will be record throughout the study.

Healthy participants will only be assessed once to provide normative data.

02

Conditions studied

  • Osteoarthritis, Knee

Keywords

  • Total Knee Arthroplasty
  • Medial Pivot Knee Implant Design
  • Knee Joint Mechanics
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 162 is above the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Lady Davis Institute is the lead sponsor of 46 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals diagnosed with osteoarthritis, who in the opinion of the investigator, are suitable candidates for primary total knee replacement using the devices specified in the protocol;
  • Males and females between 18 - 80 years at the time of surgery;
  • Individuals who understand the conditions of the study and are willing and able to provide for participation in the study;
  • Individuals who are willing and able to participate for the length of the prescribed term of follow-up;
  • Individuals who are willing and able to complete all the assessments specified by the study protocol.

Exclusion criteria

Exclusion Criteria:

  • The presence of previous failed lower extremity arthroplasty or metalwork in situ;
  • Patients with severe hip osteoarthritis;
  • Patients with lower extremity trauma requiring surgery within 1 year;
  • Patients with inflammatory arthritis, severe neurological conditions, or severe cardiovascular conditions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
162 participants (estimated)

Study arms

  • Experimental
    Zimmer MP Persona

    Zimmer MP Persona is total knee prosthesis intended to resurface the articulating surface of the femoral, tibial and patellar bones. It employs modular components between the tibial plates and articular surfaces and a medial congruent bearing manufactured from Vivacit-E Highly Crosslinked Polyethylene (HXPE). Persona® Medial Congruent Bearing is available in several sizes and offers up to a 13mm anterior lip height to provide greater anterior constraint and subluxation resistance. Can be used with a with both cruciate retaining and posterior stabilized femoral provisionals

    Device: Zimmer MP Persona

  • Active comparator
    Zimmer Persona Knee-PS

    Zimmer Biomet Persona® Knee-PS is a semiconstrained knee prosthesis that employs modular components between the tibial plates and articular surfaces. The device is intended to resurface the articulating surface of the femoral, tibial and patellar bones. The posterior stabilized (PS) femoral provisionals and components can be used with the PS or constrained posterior stabilized (CPS) bearings provisionals and components when the PCL is deficient and removed.The Persona Femur offers 21 distinct profiles, in 2 mm increments.

    Device: Zimmer Persona Knee-PS

  • No intervention
    Healthy Participants

    The control group for the kinematic assessment

Interventions

  • DeviceZimmer MP Persona

    The medial pivot Persona® knee implant with a Medial Congruent™ Bearing

    Also known as: Medial Pivot Persona, Persona knee implant with a Medial Congruent Bearing

  • DeviceZimmer Persona Knee-PS

    Persona the personalized knee system

06

What researchers measure

Primary outcomes

  1. Knee mechanics

    nee motion will be assessed using 3-dimensional optical motion capture sampled at 100 Hz, floor and step mounted force plates sampled at 2000 Hz, and wireless 16-channel electromyography (EMG) system sampled at 2000 Hz. Knee motion trials will require participants to ambulate at self-selected speeds over 8 meters followed by complete step up/down trials on a 20 cm step. For step up, the surgical limb will be placed on the step to start while for step down, both limbs will start on the step. The order of step up and down trials will be randomized. Participants will perform 2 practice trials followed by testing. Testing will proceed until 5 successful trials of each activity are collected. They will be allowed 30 seconds of rest between trials. The primary motion capture variables will include principal component scores that capture changes in range of motion for knee rotation and flexion angles for each activity.

    Time frame: pre-operative (as baseline) and at 1 and 2 years following TKA

Secondary outcomes

  1. Muscle activation

    Muscle activation will be measured by surface electrodes placed bilaterally over the following muscles: vastus lateralis and medialis, rectus femoris, lateral (biceps femoris) and medial (semitendinosus) hamstrings, and lateral and medial gastrocnemius. The isometric exercises will include: 1) knee extension in sitting with the knee in 45 degrees of flexion; 2) knee flexion in sitting with the knee at 55 degrees of flexion; 3) ankle plantarflexion in long sitting with the ankle in neutral; and 4) standing unilateral heel rise. Participants will perform 1 practice and 2 collection trials for each exercise. They will be allowed 30 seconds of rest between trials.

    Time frame: pre-operative (as baseline) and at 1 and 2 years following TKA

  2. The 30 seconds Chair Test - Physical Function Performance Test

    Participants will be asked to complete "the 30 seconds Chair Test", a physical function performance test measuring the maximum number of sit-to-stand repetitions on a standard chair with a seat height = 46 cm.

    Time frame: at 1 and 2 years following TKA

  3. The Stair Climb Test - Physical Function Performance Test

    After resting for 5 minutes, the participants will be asked to complete "the Stair Climb Test", a physical function performance test assessing the time \[seconds\] to ascend and descend a 11-step stair, each step 16 cm high.

    Time frame: at 1 and 2 years following TKA

  4. The 6 Minutes Walk Test - Physical Function Performance Test

    After resting for 5 minutes, the participants will be asked to complete "the 6 Minutes Walk Test", a physical function performance test measuring the distance \[meters\] ambulate in 6 minutes. The participants will be allowed to rest during the test but the timer will not be stopped.

    Time frame: at 1 and 2 years following TKA

  5. Knee Osteoarthritis and Outcome Score (KOOS) Self-Evaluation Questionnaire for Implant Performance

    Participants will be asked to complete the "Knee Osteoarthritis and Outcome Score (KOOS)" questionnaire. The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used, and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.

    Time frame: pre-operative (as baseline) and at 1 and 2 years following TKA

  6. EQ-5D-5L Self-Evaluation Questionnaire for Implant Performance

    Participants will be asked to complete the "EQ-5D-5L" questionnaire, a measure of health-related quality of life that comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    Time frame: pre-operative (as baseline) and at 1 and 2 years following TKA

  7. Global Rating of Change (GRC) Self-Evaluation Questionnaire for Implant Performance

    Participants will be asked to complete the GRC questionnaire to rate the improvement or deterioration over time compared to the pre-operative visit. The GRC is a 15-point scale (-7=Worse, +7=Better) to assess the participant current health status, recall that status at a previous time-point, and then calculate the difference between the two. The magnitude of this difference will be scored on a numerical or visual analogue scale.

    Time frame: pre-operative (as baseline) and at 1 and 2 years following TKA

  8. Sensitivity to Physical Activity

    Sensitivity to Physical Activity will quantify the pain response to standardized physical activity. Participants will be required to rate their pain before and after each Physical Function Performance Tests using a 0 (no pain) to 100 (most pain imaginable) numeric rating scale. To determine the SPA for each test, the pain before the test will be subtracted from the pain after the test.

    Time frame: at 1 and 2 years following TKA

  9. Radiographs

    Radiographs (anteroposterior hip to ankle, standing anteroposterior; standing lateral and patellar axial views) will be taken pre-operatively, intra operatively and at 6 weeks, 1 year and 2 years post-operatively as part of standard care. Radiographic evaluation will consist of the assessment of limb alignment, component position, and presence of radiolucencies or osteolysis. Longitudinal changes of posterior femoral condylar offset and the degree of posterior tibial slope after the surgery will be also determined.

    Time frame: pre-operatively, intra operatively and at 6 weeks, 1 year and 2 years post-operatively

  10. Adverse Events

    Adverse events and unplanned hospital visits will be tracked and documented. This includes wound related problems (infections), deep vein thrombosis, pulmonary embolism, stiffness, implant loosening, implant instability, re-operation or removal of any components for any reason.

    Time frame: intra operatively and at 6 weeks, 1 year and 2 years post-operatively

Other outcomes

  1. Maximum Voluntary Isometric Contractions (MVIC)

    Following gait trials, participants will complete a series of four maximum voluntary isometric contractions (MVIC) as follows: 1) knee extension in sitting with the knee in 45o of flexion; 2) knee flexion in sitting with the knee at 55o of flexion; 3) ankle plantarflexion in long sitting with the ankle in neutral; and 4) standing unilateral heel rise. MVIC exercises 1-3 will be performed on an isokinetic dynamometer. Participants will perform 1 practice and 2 collection trials for each exercise. They will be allowed 30 seconds of rest between trials. The MVIC will be used to normalize the amplitude of EMG waveforms.

    Time frame: pre-operative (as baseline) and at 1 and 2 years following TKA

07

Study locations

3 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03681977
Lead sponsor
Lady Davis Institute
Collaborators
Jewish General Hospital, McGill University, Zimmer Biomet, Montreal General Hospital
Responsible party
John Antoniou, MD PhD (Principal Investigator, Research Director of the Division of Orthopaedic Surgery McGill University, Profesor of Surgery McGill University., Lady Davis Institute) — Principal investigator
First posted
Sep 24, 2018
Start date
Sep 1, 2019
Primary completion
Dec 31, 2025 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Jul 12, 2024

Study contacts

John Antoniou, MD, PhD
principal investigator · Jewish General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion